Minimally Invasive Radical Nephroureterectomy: 5-Year Update of Techniques and Outcomes

Author:

Franco Antonio12,Ditonno Francesco13ORCID,Feng Carol1,Manfredi Celeste14ORCID,Sturgis Morgan R.1,Farooqi Mustafa1ORCID,Del Giudice Francesco5ORCID,Coogan Christopher1,Ferro Matteo6ORCID,Zhang Chao7,Wu Zhenjie7,Yang Bo7,Wang Linhui7,Autorino Riccardo1ORCID

Affiliation:

1. Department of Urology, Rush University, Chicago, IL 60612, USA

2. Department of Urology, Sant’Andrea Hospital, Sapienza University, 00189 Rome, Italy

3. Department of Urology, Azienda Ospedaliera Universitaria Integrata Verona, University of Verona, 37126 Verona, Italy

4. Urology Unit, Department of Woman, Child and General and Specialized Surgery, University of Campania “Luigi Vanvitelli”, 80138 Naples, Italy

5. Department of Maternal Infant and Urologic Sciences, Policlinico Umberto I Hospital, “Sapienza” University of Rome, 00161 Rome, Italy

6. Division of Urology, European Institute of Oncology (IEO), IRCCS, 20141 Milan, Italy

7. Department of Urology, Changhai Hospital, Naval Medical University, Shanghai 200433, China

Abstract

The gold standard treatment for non-metastatic upper tract urothelial cancer (UTUC) is represented by radical nephroureterectomy (RNU). The choice of surgical technique in performing UTUC surgery continues to depend on several factors, including the location and extent of the tumor, the patient’s overall health, and very importantly, the surgeon’s skill, experience, and preference. Although open and laparoscopic approaches are well-established treatments, evidence regarding robot-assisted radical nephroureterectomy (RANU) is growing. Aim of our study was to perform a critical review on the evidence of the last 5 years regarding surgical techniques and outcomes of minimally invasive RNU, mostly focusing on RANU. Reported oncological and function outcomes suggest that minimally invasive RNU is safe and effective, showing similar survival rates compared to the open approach.

Publisher

MDPI AG

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3